- Importer SMS refuses to present timeframe relating to supply of vaccine
- Importer says Serum Institute in India to offer vaccine in India after which export it to Pakistan
- Importer warns authorities of remaining cautious of individuals and companies attempting to reap the benefits of state of affairs
KARACHI: The federal and provincial governments have been provided to purchase the Oxford-AstraZeneca’s coronavirus vaccine for $6-7 by a Pakistani importer in the event that they procure the vital drug in bulk, reported The Information on Thursday.
Nonetheless, Sindh Medical Shops (SMS) has not given a timeframe as to when it will have the ability to ship the vaccine to the nation.
SMS was allowed to import the Oxford-AstraZeneca’s vaccine in Pakistan by the Drug Regulatory Authority of Pakistan (DRAP) on Friday. The approval was given on the suggestions of an specialists panel that requested DRAP to present emergency use authorisation to the British-Swedish multinational firm’s AZD-1222 vaccine within the nation.
“After getting the emergency use authorisation and permission from the DRAP to import the Oxford-AstraZeneca’s AZD1222 vaccine in Pakistan, we have offered to provide it for USD 6-7 per dose to the federal and provincial governments. We, however, don’t know when we would be able to get hold of the first consignment of the vaccine as it has been already purchased by the several countries of the world,” SMS official Usman Ghani instructed The Information.
Learn extra: Pakistan to get first coronavirus vaccine doses ‘inside weeks’, says Dr Faisal Sultan
The official shared that SMS will have the ability to present the British firm’s vaccine $6-7 per dose, making it Rs1,000 to 1,200 per dose if the federal government agrees to purchase 30 to 50 million doses.
“For the private sector and institutions, we have offered to provide it for Rs2,000 to Rs2,500 per dose if they order 10,000 or more doses. But it should be very clear that we would only be providing the vaccine to reputed institutions like Aga Khan University Hospital (AKUH), Shaukat Khanum hospital and others,” Usman Ghani added.
To a query in regards to the supply of the vaccine, Ghani stated that he couldn’t share the precise date as AstraZeneca was supplying it to different nations which had already booked and paid for the vaccine prematurely.
“AstraZeneca has authorised to manufacture the vaccine in the Serum Institute of India, Pune, for bulk production but most of the production would be used for vaccinating a sizeable population of India before it is allowed to Pakistan. We have very good business relations with the Serum Institute of India and we would try our best to procure it as early as possible,” he added.
Learn extra: How a lot would Pfizer, Moderna and Oxford vaccines price in Pakistan?
The SMS official warned the federal government to stay cautious of individuals and companies attempting to reap the benefits of the state of affairs by promoting the vaccine to the federal government between $13.5 to $15.5. He clarified that his organisation was the “sole importer” and authorised brokers of the British agency AstraZeneca.
“Similarly, there are reports that we have offered to supply the vaccine in thousands of rupees per dose, which is also incorrect and misleading. We cannot supply any product without the approval of DRAP and we hope that it would approve the vaccine price, which we have demanded,” he added.
Following the emergency use authorisation to each the British and Chinese language vaccines, the matter has been forwarded to DRAP’s pricing board, an official of the DRAP instructed The Information, saying with out the approval of pricing board, no product might be bought in Pakistan.